• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.

作者信息

Mortarelli E A

机构信息

Department of Pathology, State University of New York School of Medicine and Biomedical Sciences, Buffalo 14214.

出版信息

Ann Clin Lab Sci. 1992 Jul-Aug;22(4):201-6.

PMID:1380223
Abstract

The clinical application of 84 prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) measurements for the follow-up of 36 patients with treated prostate cancer was retrospectively examined by case study. Clinicians use several risk markers including serum levels of PSA and PAP to monitor prostate cancer progression or stability. These results of PAP and PSA tests were either utilized during the patient's clinical assessment or they were disregarded. In either case, the results would support or counter the physician's clinical decision for patient management. After predictive value analysis it was concluded that measurement of PSA alone is more useful than parallel measurements of PSA and PAP, when utilized together with standard criteria for assessing treated prostate cancer patients.

摘要

相似文献

1
Prostate specific antigen and prostatic acid phosphatase measurements for the follow-up of patients with prostate cancer.
Ann Clin Lab Sci. 1992 Jul-Aug;22(4):201-6.
2
[Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].[测定前列腺特异性抗原和前列腺酸性磷酸酶作为前列腺癌的肿瘤标志物]
Arch Esp Urol. 1989;42 Suppl 2:124-30.
3
Diagnostic value of prostatic acid phosphatase and prostate-specific antigen in patients with prostatic cancer.前列腺酸性磷酸酶和前列腺特异性抗原在前列腺癌患者中的诊断价值。
J Nucl Med Allied Sci. 1990 Oct-Dec;34(4 Suppl):85-7.
4
Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.未治疗的前列腺癌和良性前列腺增生中前列腺特异性抗原和前列腺酸性磷酸酶的评估。
Scand J Urol Nephrol Suppl. 1991;138:97-103.
5
Cross-comparison of PSA and PAP values in a wide spectrum of prostate cancer conditions.在广泛的前列腺癌病症中对前列腺特异性抗原（PSA）和前列腺酸性磷酸酶（PAP）值进行交叉比较。
Anticancer Res. 1988 Jul-Aug;8(4):569-72.
6
Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.前列腺特异性抗原作为前列腺腺癌的血清标志物。
N Engl J Med. 1987 Oct 8;317(15):909-16. doi: 10.1056/NEJM198710083171501.
7
Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.未诊断的偶然癌标志物与临床前列腺癌的比较。
J Med. 2000;31(1-2):101-10.
8
[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma].[前列腺酸性磷酸酶与前列腺特异性抗原在前列腺癌诊断中的比较]
Ned Tijdschr Geneeskd. 1990 Aug 18;134(33):1596-600.
9
[Clinical studies on tumor markers for monitoring prostate cancer patients; the evaluation of prostate-specific antigen and comparison with prostatic acid phosphatase and gamma-seminoprotein].[用于监测前列腺癌患者的肿瘤标志物的临床研究；前列腺特异性抗原的评估以及与前列腺酸性磷酸酶和γ-精浆蛋白的比较]
Nihon Gan Chiryo Gakkai Shi. 1990 Nov 20;25(11):2627-39.
10
Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.对原发性和转移性前列腺癌患者进行治疗后，连续测量组织多肽特异性抗原（TPS）、前列腺特异性抗原（PSA）、前列腺酸性磷酸酶（PAP）和癌胚抗原（CEA）的血清检测值。
Anticancer Res. 1993 May-Jun;13(3):769-77.